Fascia iliaca block

Surgical approach (where relevant)

  • Not a surgical operation; used to facilitate/optimise care around hip/femur surgery and ED management
  • Typical perioperative contexts
    • Neck of femur fracture: pre-op analgesia, positioning for spinal, opioid-sparing, delirium reduction strategy
    • Femoral shaft fracture, femoral neck/acetabulum injuries (variable coverage)
    • Post-op analgesia after hip arthroplasty/hip fracture fixation (as part of multimodal plan)

Anaesthetic management (typical scenarios)

  • Type of anaesthesia
    • Analgesic regional block; performed awake/sedated; commonly adjunct to spinal for NOF fracture surgery
    • Can be used with GA or neuraxial; does not replace anaesthesia for surgery
  • Airway (if in theatre)
    • If GA: ETT or SGA depending on surgery/aspiration risk; NOF patients often higher aspiration risk and frail—individualise
  • Duration
    • Block performance: ~5–10 min (ultrasound), onset typically 10–30 min depending on LA and volume
    • Analgesia duration: ~6–18 h (agent dependent; longer with adjuncts/catheters)
  • How painful is the underlying condition/surgery?
    • Hip fracture and femoral fractures: severe pain; movement/positioning very painful; high opioid sensitivity in elderly
    • Hip arthroplasty/fixation: moderate–severe post-op pain; multimodal analgesia required

Indications and aims

  • Analgesia for hip fracture, femoral fractures, anterior thigh pain; facilitates positioning for spinal/transfer/imaging
  • Opioid-sparing in frail elderly (reduce nausea, respiratory depression, delirium risk; improve mobilisation/physio participation)
  • Can be delivered as single-shot or catheter (continuous infusion/intermittent bolus) for ongoing analgesia

Relevant anatomy (exam core)

  • Target plane: beneath fascia iliaca, superficial to iliopsoas muscle (iliacus) in the iliac fossa
  • Nerves potentially affected
    • Femoral nerve (L2–L4): anterior thigh sensation; quadriceps motor; contributes to hip pain
    • Lateral femoral cutaneous nerve (L2–L3): lateral thigh sensation
    • Obturator nerve (L2–L4): medial thigh sensation; adductor motor; often inconsistently blocked with classic infra-inguinal FIB
      • More reliable obturator coverage with proximal/“supra-inguinal” approach (spread towards lumbar plexus)
  • Key landmarks/structures on ultrasound (infra-inguinal approach)
    • Femoral artery (medial), femoral nerve (lateral to artery, under fascia iliaca), iliopsoas muscle deep
    • Fascia lata (superficial) and fascia iliaca (deeper) are two distinct hyperechoic lines
  • Dermatomal/clinical effect (typical)
    • Reduced pain from hip fracture/anterior thigh; variable lateral thigh numbness; quadriceps weakness possible

Techniques (what you should be able to describe in a viva)

  • Approaches
    • Infra-inguinal (classic): injection below fascia iliaca lateral to femoral nerve/artery at inguinal crease
    • Supra-inguinal: injection cephalad to inguinal ligament to encourage proximal spread (better LFCN/obturator coverage)
    • Landmark (loss-of-resistance “two pops”): less reliable and higher risk of failure/complications vs ultrasound
  • Ultrasound-guided infra-inguinal: stepwise
    • Position: supine; slight external rotation; expose inguinal region; consider analgesia/sedation cautiously
    • Probe: high-frequency linear; transverse at inguinal crease; identify femoral artery then femoral nerve lateral
    • Identify fascia lata and fascia iliaca; aim needle tip under fascia iliaca (not just under fascia lata)
    • Needle: in-plane lateral-to-medial commonly; aspirate; hydrodissect with small aliquots to confirm correct plane
    • Inject large volume to promote spread laterally/cephalad; observe separation of fascia iliaca from iliopsoas and spread around femoral nerve
  • Supra-inguinal: stepwise (high-yield differences)
    • Probe placed just medial to ASIS, oriented to visualise iliacus muscle and fascia iliaca; needle advanced to plane deep to fascia iliaca
    • Aim for cranial spread towards iliac fossa/lumbar plexus to improve LFCN and obturator involvement

Local anaesthetic choice, dose and practical prescribing (UK exam style)

  • Principle: FIB is a fascial plane block → success depends on volume and correct plane more than precise nerve contact
  • Typical single-shot volumes (adult)
    • Infra-inguinal: 30–40 mL commonly used (adjust to patient size, frailty, and maximum safe dose)
    • Supra-inguinal: often 30–40 mL; may achieve better proximal spread at similar volumes
  • Common LA regimens (examples; always calculate maximum safe dose and consider frailty)
    • Ropivacaine 0.2–0.375% 30–40 mL (good sensory with less motor than bupivacaine at equipotent doses)
    • Levobupivacaine 0.25% 30–40 mL (longer duration; more motor block possible)
    • Lidocaine 1% (with/without adrenaline) for faster onset if needed; shorter duration
  • Adjuvants
    • Dexamethasone (perineural/off-label) may prolong duration; consider local policy and consent
    • Avoid mixing multiple LAs without clear rationale; increases dosing complexity and toxicity risk
  • Catheter technique (if used)
    • Thread catheter 3–5 cm in plane under fascia iliaca; secure well; label; document sensory/motor baseline
    • Infusion examples: ropivacaine 0.2% at 5–10 mL/h or intermittent bolus per local protocol; monitor quadriceps strength and falls risk

Contraindications and precautions

  • Absolute
    • Patient refusal, allergy to LA, infection at injection site
  • Relative / caution
    • Anticoagulation: FIB is a superficial fascial plane block (generally lower bleeding risk than deep plexus blocks) but still consider compressibility, local policy, and patient-specific risk
    • Sepsis/systemic infection (risk–benefit); altered anatomy; previous groin surgery
    • Severe hypovolaemia/shock: prioritise resuscitation; avoid masking evolving compartment/ischemic pain (rare context)
    • Pre-existing femoral neuropathy: document baseline deficits; counsel re attribution

Complications and how to reduce them

  • Local anaesthetic systemic toxicity (LAST)
    • Risk increased by large volumes, frailty, low body weight, hepatic dysfunction, inadvertent intravascular injection
    • Mitigation: dose calculation, incremental injection with aspiration, ultrasound visualisation, consider adrenaline marker dose if appropriate, monitoring
    • Management: stop injection, call for help, airway/oxygen/ventilation, treat seizures, lipid emulsion, manage arrhythmias per guidelines
  • Vascular puncture/haematoma
    • Avoid medial needle trajectory; identify femoral vessels; use colour Doppler if uncertain; compress if puncture
  • Nerve injury
    • Less likely than femoral nerve block (needle not aimed at nerve), but still possible; avoid intraneural injection; stop if pain/paraesthesia/high pressure
  • Block failure / incomplete analgesia
    • Common causes: injection above fascia iliaca (only under fascia lata), inadequate volume, poor spread, wrong approach for pain source (posterior hip pain)
    • Management: reassess anatomy, consider repeat under ultrasound within safe dosing, add systemic analgesia, consider alternative blocks (PENG, femoral, LPB) depending on indication and expertise
  • Motor weakness and falls risk
    • Quadriceps weakness can occur; ensure mobilisation plan accounts for this; document and communicate to ward/physio; consider lower concentration/ropivacaine
  • Infection (especially catheters)
    • Asepsis, sterile probe cover/gel, secure dressing, daily review and timely removal

Comparison with related blocks (frequent viva theme)

  • FIB vs femoral nerve block
    • FIB: fascial plane, larger volume, potentially covers femoral + LFCN (± obturator), less needle-near-nerve; good for hip fracture pathways
    • Femoral nerve block: targeted femoral nerve, reliable anterior thigh analgesia, more direct motor block; may miss LFCN/obturator
  • FIB vs PENG block (pericapsular nerve group)
    • PENG aims at articular branches to anterior hip capsule (femoral, obturator, accessory obturator) and may be more motor-sparing; technique-dependent and evolving evidence base
    • FIB is simpler, widely taught; may provide broader cutaneous coverage but can cause quadriceps weakness
  • FIB vs lumbar plexus block
    • Lumbar plexus block is deep, higher bleeding/neuraxial spread risk; requires expertise; stronger analgesia/coverage but greater complication profile

Documentation and governance (often tested indirectly)

  • Record: indication, consent, side, technique (US/landmark), needle approach, LA drug/concentration/volume, total dose (mg), aspiration, complications, sensory/motor assessment, post-block instructions
  • Communicate falls risk and mobilisation advice; ensure ward knows block performed and expected duration
Describe how you would perform an ultrasound-guided infra-inguinal fascia iliaca block for a patient with a fractured neck of femur.

Aim: deposit LA deep to fascia iliaca to allow spread to femoral nerve and LFCN (± obturator).

  • Preparation: confirm indication, consent/capacity, allergies, anticoagulation status, baseline neuro exam, monitoring (ECG/NIBP/SpO2), IV access, resus drugs and lipid available
  • Position: supine; expose groin; analgesia/sedation cautiously (frail elderly; avoid oversedation)
  • Asepsis: sterile gloves, skin prep, sterile probe cover and gel
  • Scan: linear probe transverse at inguinal crease; identify femoral artery then femoral nerve lateral; identify fascia lata and fascia iliaca
  • Needle: in-plane lateral-to-medial; advance to just deep to fascia iliaca; confirm with hydrodissection
  • Inject: incremental aliquots with aspiration; aim for spread under fascia iliaca laterally/cephalad; total volume typically 30–40 mL within safe dose
  • Aftercare: monitor for LAST; document; reassess pain and quadriceps strength; communicate falls risk and expected duration
Which nerves does a fascia iliaca block cover, and why can it be unreliable for obturator nerve blockade?

Coverage depends on LA spread within the fascia iliaca compartment.

  • Most consistent: femoral nerve; often: lateral femoral cutaneous nerve
  • Obturator nerve: inconsistent with infra-inguinal approach because obturator lies more medial/deeper and outside the main spread pathway; requires more proximal spread (supra-inguinal) to improve likelihood
  • Clinical implication: hip fracture pain may persist (especially medial thigh/adductor-related or posterior capsule pain) despite a technically correct infra-inguinal FIB
Explain the ultrasound anatomy you expect to see for an infra-inguinal fascia iliaca block.

Key is distinguishing fascia lata from fascia iliaca and locating femoral vessels/nerve.

  • Femoral artery (pulsatile, anechoic lumen) with femoral vein medial; femoral nerve hyperechoic/oval lateral to artery
  • Two fascial layers: fascia lata superficial; fascia iliaca deeper over iliopsoas/iliacus
  • Target plane: deep to fascia iliaca; correct injection separates fascia iliaca from iliopsoas with visible LA spread
What local anaesthetic and volume would you choose for a fascia iliaca block in a 50 kg frail elderly patient? Talk through your safety considerations.

FRCA focus: safe dosing, frailty, large-volume plane block, LAST mitigation.

  • Choose a long-acting LA at lower concentration to allow volume while staying within maximum dose (e.g., ropivacaine 0.2–0.25% or levobupivacaine 0.125–0.25%)
  • Calculate maximum safe dose (mg/kg) and reduce further for frailty/low muscle mass; consider using 25–30 mL rather than 40 mL if dose-limited
  • Inject incrementally with aspiration; use ultrasound to avoid intravascular injection; monitor closely and have lipid immediately available
  • Balance analgesia vs motor block/falls risk; communicate to ward and physio
A patient becomes agitated and then has a seizure shortly after you inject local anaesthetic for a fascia iliaca block. What is your diagnosis and immediate management?

This is presumed LAST until proven otherwise.

  • Stop injection; call for help; ABC approach with 100% oxygen; support ventilation to avoid hypercarbia/acidosis
  • Treat seizures: benzodiazepine first line; avoid large propofol doses in cardiovascular instability
  • Start lipid emulsion therapy per guideline; continue resuscitation and manage arrhythmias (avoid lidocaine; cautious with adrenaline dosing)
  • Post-event: ICU/HDU monitoring; document and report; review dosing and technique
How does a supra-inguinal fascia iliaca block differ from an infra-inguinal approach, and what are the potential advantages?

Difference is injection site relative to inguinal ligament and intended proximal spread.

  • Supra-inguinal is performed cephalad to inguinal ligament near ASIS with the aim of cranial spread in iliac fossa
  • Potential advantages: improved LFCN block and higher chance of obturator involvement; may provide better hip analgesia
  • Same safety principles: large volume, dose limitation, LAST vigilance
Your fascia iliaca block has not worked. Give a structured approach to troubleshooting.

Think: wrong patient/problem, wrong plane, wrong dose/volume, wrong time, or alternative pain source.

  • Reassess pain source: posterior hip pain or non-femoral distribution may not respond; consider PENG or alternative strategies
  • Check timing: allow adequate onset (10–30 min depending on LA)
  • Review technique: was LA injected under fascia iliaca (not just under fascia lata)? Was spread seen? Adequate volume?
  • If safe: repeat under ultrasound within maximum dose; otherwise add systemic analgesia and non-opioid adjuncts
  • Document and communicate; consider senior help for alternative blocks
Discuss the risks and benefits of fascia iliaca block in an anticoagulated patient with a hip fracture.

FRCA expects risk stratification and pragmatic governance.

  • Benefit: strong opioid-sparing analgesia facilitating care and neuraxial positioning; may reduce delirium/respiratory complications
  • Bleeding risk: generally lower than deep plexus blocks because it is superficial and compressible, but vascular puncture/haematoma still possible
  • Approach: check drug/timing/renal function; follow local/regional anaesthesia anticoagulation guidance; use ultrasound to avoid vessels; apply compression if needed
  • Communicate and document shared decision-making; monitor for expanding haematoma or neurovascular compromise
What are the key points you would include when consenting a patient for a fascia iliaca block?

Consent should be proportionate, patient-specific, and documented.

  • Benefits: improved pain control, less opioid, easier movement/positioning, possibly reduced nausea/delirium
  • Common/important risks: failure/incomplete block, bruising/bleeding, infection, temporary leg weakness/numbness and falls risk
  • Serious but rare: LAST (seizure/cardiac arrest), nerve injury
  • Alternatives: systemic analgesia, other regional blocks, no block
How would you assess and document block success after a fascia iliaca block?

Assess pain and function, not just sensation.

  • Pain scores at rest and on movement (e.g., passive leg raise/roll), opioid requirements, ability to tolerate positioning
  • Sensory testing: anterior thigh (femoral), lateral thigh (LFCN), medial thigh (obturator—often unreliable)
  • Motor: quadriceps strength (knee extension/straight leg raise) and mobilisation advice/falls precautions
  • Document timing, findings, and any adverse events
You are asked to provide analgesia for an 86-year-old with a fractured neck of femur in ED. Discuss the role of fascia iliaca block and how you would deliver it safely.

Structure: indication/benefits → assessment/consent → technique → dosing → monitoring/complications → governance.

  • Role: early analgesia, opioid-sparing, facilitate movement/positioning for spinal, potentially reduce delirium/respiratory depression
  • Assessment: pain severity, cognition/capacity, allergy, anticoagulants, infection, baseline neuro status, haemodynamic stability
  • Safety setup: monitoring, IV access, resus equipment, lipid available, trained assistant if possible
  • Technique: ultrasound-guided preferred; identify fascia lata vs fascia iliaca; inject deep to fascia iliaca with adequate volume; incremental injection and aspiration
  • Dosing: choose LA and volume within safe mg/kg; reduce dose for frailty/low weight; avoid exceeding maximum when combined with other LAs (e.g., later spinal infiltration)
  • Aftercare: reassess pain and motor function; falls precautions; document and handover; plan for breakthrough pain
  • Complications: LAST, vascular puncture/haematoma, infection, nerve injury, block failure; provide immediate management plan for LAST
Compare fascia iliaca block with femoral nerve block for hip fracture analgesia. Include anatomy, technique, efficacy, and complications.

Examiner expects a balanced comparison and clinical implications.

  • Anatomy/coverage: FIB targets plane to cover femoral + LFCN (± obturator); femoral block reliably covers femoral nerve only
  • Technique: FIB is plane block with large volume; femoral block is perineural targeted injection; both can be ultrasound-guided
  • Efficacy: both reduce pain; FIB may provide broader cutaneous coverage; obturator involvement is variable (better with supra-inguinal FIB)
  • Complications: both—LAST/bleeding/infection; femoral block may have higher risk of direct nerve trauma; both may cause quadriceps weakness and falls risk
  • Practical: FIB often favoured in pathways due to simplicity and distance from nerve; femoral block useful when targeted femoral analgesia is desired
Outline the management of local anaesthetic systemic toxicity (LAST) in the context of a high-volume fascial plane block.

Must include immediate actions, seizure management, lipid, and modified ALS.

  • Recognise early CNS signs (tinnitus, metallic taste, agitation) progressing to seizures; CVS collapse may occur
  • Immediate: stop LA, call for help, airway management, 100% O2, ventilate to normocapnia
  • Seizure control: benzodiazepines; consider small propofol only if stable; avoid hypoxia/acidosis
  • Lipid emulsion: start promptly per guideline; continue supportive care and treat arrhythmias appropriately
  • If cardiac arrest: high-quality CPR; modify adrenaline dosing; avoid vasopressin and LA antiarrhythmics; continue lipid and prolonged resuscitation if needed
  • Post-resuscitation: ICU/HDU; incident reporting; review dosing/technique and patient factors

0 comments